Effects of amphetamine-induced dopamine release and raclopride-induced dopamine blockade on psychiatric symptoms and tics of subjects with and without Gilles de la Tourette syndrome

被引：0
|
作者：
Brasic, James Robert [1 ]
Singer, Harvey [1 ]
Raymont, Vanessa [1 ]
Zaidi, Eram [1 ]
Gean, Emily [1 ]
Mathur, Anil [1 ]
Darnley, Stefanie [1 ]
Mellinger-Pilgrim, Rebecca [1 ]
Maris, Marika [1 ]
Wong, Dean F. [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源：
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM | 2012年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S92 / S92
页数：1
相关论文
共 41 条
  • [31] Long-term opiate effects on amphetamine-induced dopamine release in the nucleus accumbens core and conditioned place preference
    He, ST
    Li, N
    Grasing, K
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2004, 77 (02) : 327 - 335
  • [32] Direct and Systemic Administration of a CNS-Permeant Tamoxifen Analog Reduces Amphetamine-Induced Dopamine Release and Reinforcing Effects
    Colleen Carpenter
    Alexander G Zestos
    Rachel Altshuler
    Roderick J Sorenson
    Bipasha Guptaroy
    Hollis D Showalter
    Robert T Kennedy
    Emily Jutkiewicz
    Margaret E Gnegy
    Neuropsychopharmacology, 2017, 42 : 1940 - 1949
  • [33] Zn2+ modulates currents generated by the dopamine transporter:: parallel effects on amphetamine-induced charge transfer and release
    Pifl, C
    Rebernik, P
    Kattinger, A
    Reither, H
    NEUROPHARMACOLOGY, 2004, 46 (02) : 223 - 231
  • [34] Direct and Systemic Administration of a CNS-Permeant Tamoxifen Analog Reduces Amphetamine-Induced Dopamine Release and Reinforcing Effects
    Carpenter, Colleen
    Zestos, Alexander G.
    Altshuler, Rachel
    Sorenson, Roderick J.
    Guptaroy, Bipasha
    Showalter, Hollis D.
    Kennedy, Robert T.
    Jutkiewicz, Emily
    Gnegy, Margaret E.
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 (10) : 1940 - 1949
  • [35] DOPAMINE-RECEPTOR BLOCKADE INHIBITS THE AMPHETAMINE-INDUCED RELEASE OF DIADENOSINE POLYPHOSPHATES, DIADENOSINE TETRAPHOSPHATE AND DIADENOSINE PENTAPHOSPHATE, FROM NEOSTRIATUM OF THE CONSCIOUS RAT
    PINTOR, J
    PORRAS, A
    MORA, F
    MIRASPORTUGAL, MT
    JOURNAL OF NEUROCHEMISTRY, 1995, 64 (02) : 670 - 676
  • [36] Amphetamine-induced release of dendritic dopamine in substantia nigra pars reticulata: D1-mediated behavioral and electrophysiological effects
    Timmerman, W
    Abercrombie, ED
    SYNAPSE, 1996, 23 (04) : 280 - 291
  • [37] Imaging amphetamine-induced dopamine release in striatal substructures in cocaine dependence with PET and its relationship to the positive effects of cocaine.
    Martinez, D
    Broft, A
    Foltin, R
    Perez, A
    Hwang, DR
    Huang, Y
    Hackett, L
    Mawlawi, O
    Peters, C
    Fischman, M
    Laruelle, M
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 66P - 66P
  • [38] A Comparative Evaluation of the Dopamine D2/3 Agonist Radiotracer [11C](-)-N-Propyl-norapomorphine and Antagonist [11C]Raclopride to Measure Amphetamine-Induced Dopamine Release in the Human Striatum
    Narendran, Rajesh
    Mason, N. Scott
    Laymon, Charles M.
    Lopresti, Brian J.
    Velasquez, Natalie D.
    May, Maureen A.
    Kendro, Steve
    Martinez, Diana
    Mathis, Chester A.
    Frankle, W. Gordon
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 333 (02): : 533 - 539
  • [39] Disruption of neurogenesis on gestational day 17 in the rat causes behavioral changes relevant to positive and negative schizophrenia symptoms and alters amphetamine-induced dopamine release in nucleus accumbens
    Flagstad, P
    Mork, A
    Glenthoj, BY
    van Beek, J
    Michael-Titus, AT
    Didriksen, M
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 (11) : 2052 - 2064
  • [40] Disruption of Neurogenesis on Gestational Day 17 in the Rat Causes Behavioral Changes Relevant to Positive and Negative Schizophrenia Symptoms and Alters Amphetamine-Induced Dopamine Release in Nucleus Accumbens
    Peter Flagstad
    Arne Mørk
    Birte Y Glenthøj
    Johan van Beek
    Adina T Michael-Titus
    Michael Didriksen
    Neuropsychopharmacology, 2004, 29 : 2052 - 2064
12345